ORIGINAL INVESTIGATION. Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population
|
|
- Albert Bond
- 5 years ago
- Views:
Transcription
1 ORIGINAL INVESTIGATION Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population The Health, Aging and Body Composition Study Alka M. Kanaya, MD; Fran Harris, MS; Stefano Volpato, MD; Eliseo J. Pérez-Stable, MD; Tamara Harris, MD; Douglas C. Bauer, MD Background: Thyroid dysfunction increases with age. Less is known about the prevalence of thyroid disease in older black adults and whether an association between thyroid function and serum cholesterol level exists, as in older white adults. Methods: A cross-sectional study of 2799 well functioning white and black participants, aged 70 to 79 years, were recruited for a population-based study. Participants underwent thyrotropin, free thyroxine, and total cholesterol testing; a medical history; and physical measurements. Results: Among the entire cohort, 94% were euthyroid based on biochemical testing results. Approximately 10% were taking thyroid hormones. Subclinical hypothyroidism was the most prevalent disorder (3.1% of all participants not taking thyroid hormones), but black men and women had lower rates of this condition than white men and women. After excluding those taking thyroid or lipid medication and adjusting for potential confounders, an elevated thyrotropin level ( 5.5 miu/ml) was associated with a 9 mg/dl (0.23 mmol/l) higher cholesterol level, and a suppressed thyrotropin level ( 0.35 miu/ ml) was associated with a 19 mg/dl (0.49 mmol/l) lower cholesterol level. Conclusion: Healthy community-dwelling older black adults have a lower prevalence of thyroid dysfunction compared with older white adults, but the association between increased thyrotropin and increased cholesterol levels is similar in both races. Arch Intern Med. 2002;162: From the Division of General Internal Medicine, Department of Medicine (Drs Kanaya, Pérez-Stable, and Bauer), Prevention Sciences Group (Ms F. Harris and Dr Bauer), Center for Aging in Diverse Communities (Drs Kanaya and Pérez-Stable), Medical Effectiveness Research Center for Diverse Populations (Dr Pérez-Stable), University of California, San Francisco; and the National Institute on Aging, National Institutes of Health, Bethesda, Md (Drs Volpato and T. Harris). WITH THE advent of sensitive assays for thyrotropin, isolated elevation and suppression of thyrotropin levels have been increasingly recognized in older populations. Subclinical hypothyroidism, defined as an elevated thyrotropin level with a normal serum free thyroxine (FT 4 ) concentration, occurs in 5% to 10% of patients older than 65 years and is especially prevalent in older white women. 1-9 Less information exists regarding the prevalence of subclinical hyperthyroidism in older black adults; estimated prevalences range from 2% to 12%, but results from population-based studies often have included patients receiving thyroxine treatment, which may overestimate the true prevalence. 10 Many contend that identifying and treating older patients with subclinical hypothyroidism may retard deleterious effects on the cardiovascular system, mostly via beneficial changes on lipoprotein levels. 11 The relationship between overt hypothyroidism and lipid abnormalities has been recognized for decades. Frank hypothyroidism is associated with elevated total cholesterol and low-density lipoprotein levels. 12,13 Studies investigating the relationship between lipids and subclinical hypothyroidism have shown variable results, ranging from no correlation to deleterious effects on total cholesterol, lowdensity and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins B and A1. 1,17-20 A meta-analysis 21 found that subclinical hypothyroidism is 2 to 3 times more frequent in persons with elevated cholesterol levels and that total cholesterol levels are slightly elevated in patientswithsubclinicalhypothyroidism. Similarly, intervention studies of thyroxine treatment for subclinical hypothyroidism have foundmixedresultsonlipidprofile, although the meta-analysis of 13 treatment studies found that thyroid substitution therapy resulted in an overall decrease in cholesterol of 15 mg/dl (0.4 mmol/l). 773
2 PARTICIPANTS AND METHODS STUDY DESIGN AND SETTING Participants in this cross-sectional study were enrolled in the Health, Aging and Body Composition study, an ongoing prospective cohort study of 3075 communitydwelling men and women, aged 70 to 79 years, enrolled or recruited at 2 clinical centers, in Memphis, Tenn, and Pittsburgh, Pa. To be eligible for this study, participants had to report no difficulty walking 0.4 km (one quarter mile) or up a flight of stairs. For our analyses, we used data gathered from 2799 participants who had thyrotropin test specimens, medical history, medication inventory, and physical measurements obtained at the second annual visit. All Health, Aging and Body Composition study participants were interviewed and examined at one of the clinical centers during the first and second annual visits between April 28, 1997, and June 14, MEASUREMENTS Questionnaire variables gathered from the first annual visit included self-identified racial group, level of education completed, and estimated family income. Physical activity was assessed at this visit by self-report of walking and exercise, assigning kilocalories per week to categories based on the Harvard Alumni Health Study variables. 22 In addition, participants reported smoking history (never, former, or current smoker) and alcohol use (number of drinks per week). Detailed data about physician-diagnosed medical conditions were collected at the first visit as well. Participants were asked specifically about previous diagnosis of Graves disease, hyperthyroidism, hypothyroidism, or an overactive or underactive thyroid gland. Participants were classified as having diabetes if they reported physician-diagnosed diabetes, were taking medication to control their diabetes, had a fasting serum glucose level greater than 125 mg/dl ( 6.9 mmol/l), or had a 2-hour oral glucose tolerance test result 200 mg/dl or greater than ( 11.1 mmol/l) at the baseline or second annual visit. At the second visit, their weight was measured using standardized protocols, 23 and body mass index (BMI) was calculated using the height measurement from the first visit. Trained interviewers confirmed medication used in the preceding 2 weeks by examination of pill bottles at the second visit as well. Fasting serum specimens were collected from each participant at the second annual visit. We measured thyrotropin levels by immunoassay (ACS; Chiron Diagnostics Corp, Emeryville, Calif) in 2799 participants. The normal range of thyrotropin by this assay is 0.35 to 5.5 miu/ml. The lower limit of detection of thyrotropin was 0.03 miu/ml. The coefficient of variation for thyrotropin was 4.1% at a level of miu/ml and was 3.6% at a level of 1.26 miu/ml. We routinely measured FT 4 by competitive immunoassay (ACS; Chiron Diagnostics Corp) on all of the participants with a thyrotropin value of 0.1 miu/ml or less or greater than 7.0 miu/ml. The normal range of FT 4 for this assay is 0.8 to 1.8 ng/dl (10-23 pmol/l). We determined a fasting total cholesterol level (VITROS; Johnson & Johnson, Rochester, NY ) for all participants at this visit as well. Little is known about the prevalence of thyroid dysfunction in older black adults and whether a similar association between thyroid function and cholesterol level exists among black adults, as in white adults. A crosssectional study 7 of middle-aged and older volunteers screened at health fairs found that white participants had a higher prevalence of abnormally suppressed or increased thyrotropin levels compared with black adults. We are unaware of any study that has examined the relationship between thyrotropin and cholesterol levels among older black adults. To examine the prevalence of self-reported thyroid disease and biochemically measured thyroid dysfunction and the relationship between thyroid disorders and total cholesterol levels by race, we used data from the Health, Aging and Body Composition study, a study of well functioning white and black men and women aged 70 to 79 years. We hypothesized that the black participants in this cohort might have a lower prevalence of measured thyroid dysfunction than the white participants, and that a significant relationship between thyrotropin and cholesterol levels would exist for both racial groups. RESULTS Among the entire cohort, 2799 (91%) had laboratory tests performed at the second annual visit. Sixty percent of them were white, and 51% were women. The mean age was similar among all subgroups (Table 1). men and women were more educated and reported higher family income than black men and women, respectively. Men of both races had similar mean BMIs, while black women had the highest BMIs of all. Overall, white men had the highest activity levels, and black women were the least active. Women of both races reported more known diagnoses of thyroid disease and increased use of thyroid hormones compared with men. Compared with black women, white women reported a significantly greater prevalence of known hypothyroidism (16.5% vs 6.2%, P=.001), while black women reported a higher prevalence of hyperthyroidism (9.7% vs 6.0%, P=.01). However, among the entire study population, only 2 black women were currently taking antithyroid medications. Significantly more white participants were taking lipid-lowering medications in both sex groups, and more white women were taking oral estrogen than black women. Mean values and ranges for thyrotropin, FT 4, and cholesterol for all participants are reported in Table 2. On average, FT 4 and cholesterol means were similar for both races in each sex group, but women had higher mean total cholesterol levels than men. The mean thyrotropin values were significantly higher for white men and women compared with black men and women. 774
3 DEFINITION OF THYROID DISEASE AND DYSFUNCTION Biochemically documented hypothyroidism was defined as a thyrotropin level of 7.0 miu/ml or higher and an FT 4 value of less than 0.8 ng/dl ( 10 pmol/l), while subclinical hypothyroidism was defined as a thyrotropin value of 7.0 miu/ml or higher with a normal FT 4 level. Biochemically documented hyperthyroidism was defined as a thyrotropin level of 0.1 miu/ml or less with an FT 4 value of greater than 1.8 ng/dl ( 23 pmol/l), and subclinical hyperthyroidism was defined as a suppressed thyrotropin level ( 0.1 miu/ml) with a normal FT 4. All participants with a thyrotropin value of greater than 0.1 miu/ml or less than 7.0 miu/ml were considered to be euthyroid. To distinguish between participants who were currently being treated with thyroid hormone therapy or antithyroid medications from those with laboratory evidence of a thyroid disorder, we termed the former group as those with thyroid disease and the latter group as those with thyroid dysfunction. Suboptimal thyroid treatment was evaluated for those with existing thyroid disease (hypothyroidism) who were taking thyroid hormone therapy. Participants who were not euthyroid while taking thyroid hormones were included in the analysis of suboptimal thyroid treatment. STATISTICAL ANALYSIS Means and SDs of the baseline characteristics were determined. Bivariate associations were examined by 2 test, Fisher exact test, or t test, when appropriate. Differences were considered significant at P.05. In analyzing the biochemically measured thyroid status of participants in each sex and race group, we stratified our analyses by use of thyroid hormone. Among the cohort taking thyroid hormones, we performed a stepwise logistic regression analysis to assess characteristics associated with suboptimal treatment with thyroid hormones. In addition, we evaluated the relationship of mean cholesterol levels adjusted for age, BMI, physical activity, current smoking, alcohol use, oral estrogen use, and diabetes with levels of thyroid dysfunction among those who were not taking thyroid medications or lipid-lowering drugs. We calculated a P for trend for this relationship for each sex and race subgroup. The relationship between thyrotropin and total cholesterol levels was analyzed using multivariate linear regression models, adjusting for potential confounders. Confounders were determined based on biologic plausibility (age and BMI) or strong association with serum cholesterol levels (alcohol use, oral estrogen use, and diabetes) or thyrotropin level (current smoking). Thyrotropin level was analyzed as a categorical, continuous, and log-transformed variable. All statistical analyses were performed using commercially available software (SAS, version 6.12; SAS Institute, Inc, Cary, NC). Because there were small numbers of persons with thyroid dysfunction in each sex and race subgroup and because a similar trend was seen between cholesterol level and thyroid function regardless of sex or race, we performed multivariate analyses of the entire group and adjusted for age, sex, race, BMI, current smoking, alcohol use, oral estrogen use, and diabetes. We excluded persons who were taking lipid-lowering medications, thyroid hormones, or antithyroid medications in these analyses. We performed similar analyses stratified by sex as well. Most (94%) of the cohort were euthyroid based on biochemical testing results (Table 3). The overall frequency of overt hypothyroidism and hyperthyroidism in the whole cohort was low ( 1% for each condition). Subclinical hypothyroidism was the most prevalent thyroid disorder in the entire cohort (3.9%), with white women having a significantly higher rate compared with the other 3 subgroups. Among the 271 participants taking thyroid hormones (10% of the entire cohort), most (83%) were euthyroid. women taking thyroid hormones appeared to have a lower percentage (76%) with euthyroid status compared with the other 3 sex and race subgroups (84% for the 3 subgroups combined), but this difference was not statistically significant (P=.34). Again, subclinical hypothyroidism was the most prevalent thyroid disorder overall (11.1%). We determined predictors of suboptimal treatment with thyroid hormones by stepwise logistic regression analysis. Low family income was the strongest predictor for having an abnormal thyrotropin level (P=.003), and those with the highest reported physical activity were least likely to be euthyroid (P=.03). Neither sex nor race was associated with suboptimal treatment of hypothyroidism. In analyses based on those who were not taking thyroid hormones or antithyroid medications, again subclinical hypothyroidism was the most prevalent thyroid abnormality, with white women having a significantly higher prevalence than black women (4.6% vs 1.7%, P=.005). There was a trend toward a higher prevalence of subclinical hypothyroidism in white men compared with black women (P=.06) and an equal prevalence among black men and black women. Table 4 shows adjusted mean cholesterol values by thyroid status for each sex and race strata of participants, excluding those who were taking lipid-lowering medications, thyroid hormones, or antithyroid medications. Participants with overt hypothyroidism had higher mean cholesterol values than those who were euthyroid among all subgroups. For all subgroups, there was a significant trend seen with decreasing cholesterol values for distinct levels of thyroid function, from frank biochemically documented hypothyroidism to hyperthyroidism. The only subgroup that had significantly elevated cholesterol levels associated with subclinical hypothyroidism, compared with the euthyroid state, was black women (P.001). The unadjusted cholesterol values by thyroid status for all sex and race groups were similar to these adjusted values. We performed multivariate linear regression analysis to determine whether an association existed between thyrotropin and cholesterol levels after adjusting for age, sex, race, BMI, current smoking, alcohol use, oral estrogen use, and diabetes. Similar results were obtained 775
4 Table 1. Characteristics of the Participants at the First and Second Annual Visits* Men Women Characteristic (n = 888) (n = 478) P Value (n = 797) (n = 636) P Value Mean age ± SD, y 74.9 ± ± ± ± Education, y (39.8) 350 (73.4) 411 (51.6) 460 (72.8) (60.2) 127 (26.6) 385 (48.4) 172 (27.2).001 Family income (yearly) $ (1.3) 84 (19.2) 47 (6.9) 174 (31.7) $ $ (68.9) 314 (71.9) (74.7) 362 (65.9).001 $ (29.8) 39 (8.9) 125 (18.4) 13 (2.4) Body mass index, kg/m ± ± ± ± Physical activity in prior week, kcal/wk (34.3) 262 (54.8) 418 (52.4) 439 (69.0) (29.4) 132 (27.6) (31.5) 139 (21.9) (36.3) 84 (17.6) 128 (16.1) 58 (9.1) Smoking Never 262 (29.5) 150 (31.4) 467 (58.6) 359 (56.5) Former 583 (65.7) 231 (48.3) (34.1) 202 (31.8).01 Current 43 (4.8) 97 (20.3) 58 (7.3) 75 (11.8) Alcohol, drinks/wk (55.0) 359 (75.6) 559 (70.2) 573 (90.2) (16.5) 49 (10.3) (12.8) 35 (5.5) (28.4) 67 (14.1) 135 (17.0) 27 (4.3) Self-reported medical problems Hypothyroidism 48 (5.6) 8 (1.7) (16.5) 37 (6.2).001 Hyperthyroidism 19 (2.2) 15 (3.2) (6.0) 58 (9.7).01 Diabetes 196 (22.1) 150 (31.4) (12.9) 175 (27.5).001 Current medication use at second annual visit Thyroid hormone 54 (6.1) 13 (2.7) (18.2) 59 (9.3).001 Lipid-lowering 206 (23.2) 67 (14.0) (23.2) 90 (14.2).001 Oral estrogen NA NA 261 (32.8) 86 (13.5).001 *Data are given as number (percentage) unless otherwise indicated. Percentages were calculated by dividing the number of participants with the characteristic by the total number who responded to the question, multiplied by 100. Some percentages do not sum to 100 because of rounding. The number of participants varies because of missing data for some characteristics. NA indicates not applicable. Table 2. Laboratory Values of Participants at Second Annual Visit* Men Women (n = 888) (n = 478) P Value (n = 797) (n = 636) Thyrotropin, miu/ml 2.96 ± ± ± ± Thyrotropin, range No. of participants with FT 4 testing FT 4, ng/dl 1.00 ± ± ± ± FT 4, range Cholesterol ± SD, mg/dl ± ± ± ± Cholesterol, range *Data are given as mean ± SD unless otherwise indicated. FT 4 indicates free thyroxine. To convert FT 4 from nanograms per deciliter to picomoles per liter, multiply by To convert cholesterol from milligrams per deciliter to millimoles per liter, multiply by P Value using thyrotropin level as a continuous, categorical, or log-transformed explanatory variable. We examined the results with thyrotropin levels categorized into high, normal, or low, using 2 definitions for euthyroid state ( 0.1 to 7.0 miu/ml and 0.35 to 5.5 miu/ml). For the entire cohort, a high thyrotropin level ( 5.5 miu/ml) was associated with a 9 mg/dl (0.23 mmol/l) higher total cholesterol, while a low thyrotropin level ( 0.35 miu/ml) was associated with a 19 mg/dl (0.49 mmol/l) lower total cholesterol (Table 5). Separate models were constructed for each sex, which showed similar associations between continuous and log-transformed thyrotropin levels, examined relative to cholesterol levels, while the relationship between categorical thyrotropin levels and cholesterol levels trended in the same direction, but did not reach statistical significance for many of the categories. Separate 776
5 Table 3. Prevalence of Thyroid Abnormalities by Race and Sex* Men Women Thyroid Status No. not taking thyroid drugs (n = 2526) Euthyroid 797 (95.6) 451 (97.0) 608 (93.3) 555 (96.5) Hypothyroid 5 (0.6) 2 (0.4) 7 (1.1) 4 (0.7) Subclinical hypothyroid 28 (3.4) 10 (2.2) 30 (4.6) 10 (1.7) Hyperthyroid 1 (0.1) 0 3 (0.5) 1 (0.2) Subclinical hyperthyroid 3 (0.4) 2 (0.4) 4 (0.6) 5 (0.9) No. taking thyroid hormones (n = 271) Euthyroid 46 (85.2) 12 (92.3) 121 (83.5) 45 (76.3) Hypothyroid (0.7) 4 (6.8) Subclinical hypothyroid 5 (9.3) 0 18 (12.4) 7 (11.9) Hyperthyroid (1.7) Subclinical hyperthyroid 3 (5.6) 1 (7.7) 5 (3.5) 2 (3.4) No. in total sample (N = 2797) Euthyroid 843 (94.9) 463 (96.9) 729 (91.5) 600 (94.6) Hypothyroid 5 (0.6) 2 (0.4) 8 (1.0) 8 (1.3) Subclinical hypothyroid 33 (3.7) 10 (2.1) 48 (6.0) 17 (2.7) Hyperthyroid 1 (0.1) 0 3 (0.4) 2 (0.3) Subclinical hyperthyroid 6 (0.7) 3 (0.6) 9 (1.1) 7 (1.1) *Data are given as number (percentage) unless otherwise indicated. Some percentages do not sum to 100 because of rounding. women vs black women, P =.01. women vs black women, P =.005. Excludes 2 participants who were taking antithyroid medications. women vs black women, P =.02. women vs black women, P =.003. Table 4. Cholesterol Levels by Thyroid Function for Those Not Taking Thyroid Hormones* Thyroid Status Men (n = 618) Men (n = 372) Women (n = 493) Women (n = 463) Hypothyroid (n = 13) ± ± ± ± 22.8 Subclinical hypothyroid (n = 62) ± ± ± ± 15.0 Euthyroid (n = 1858) ± ± ± ± 1.9 Subclinical hyperthyroid (n = 8) ± ± 36.6 NA ± 19.8 Hyperthyroid (n = 5) ± 34.8 NA ± ± 39.6 P for trend *Data are given as adjusted mean ± SE, unless otherwise indicated. NA indicates not applicable. To convert cholesterol from milligrams per deciliter to millimoles per liter, multiply by Table 5. Multivariate Results for the Association Between Thyrotropin and Cholesterol Levels* Entire Cohort Women Men Thyrotropin Level (95% CI) P Value Level (95% CI) P Value Level (95% CI) P Value Continuous 1.2 (0.7 to 1.7) (0.8 to 2.2) (0.2 to 1.5).01 Log 6.8 (4.5 to 9.1) (5.0 to 11.5) (1.7 to 8.2).003 Euthyroid, 0.1 to 7.0 miu/ml High 19.2 (10.3 to 28.2) (11.1 to 36.5) (1.9 to 27.2).02 Low 26.5 ( 45.6 to 7.3) ( 54.5 to 4.9) ( 51.5 to 10.6).20 Euthyroid, 0.35 to 5.5 miu/ml High 9.0 (3.4 to 15.5) (5.1 to 24.0) ( 6.1 to 12.1).51 Low 18.5 ( 32.7 to 4.3) ( 34.0 to 3.6) ( 44.7 to 0.6).04 *Adjusted for age, sex, race, body mass index, current smoking, alcohol use, oral estrogen use, and diabetes. CI indicates confidence interval. analyses of participants taking thyroid hormones but not lipid-lowering medications found significantly higher cholesterol levels for those with high thyrotropin values (15 mg/dl [0.39 mmol/l] higher total cholesterol if the thyrotropin level was 5.5 miu/ml) and a trend to lower cholesterol levels with low thyrotropin values, but these did not reach statistical significance. Among the 271 participants taking thyroid hormones, only 60 (22%) were taking lipid-lowering medications. Similarly, among the 96 participants who had 777
6 subclinical or overt hypothyroid dysfunction, 15 (16%) were taking lipid-lowering medications. The thyroid dysfunction group was not more likely to be treated with lipid-lowering agents than was the thyroid disease group (P=.17). COMMENT In this study of healthy community-dwelling older adults, the overall prevalence of any unrecognized thyroid dysfunction was lower than previously reported, and the use of thyroid supplementation was more common. Subclinical hypothyroidism was the most prevalent disorder, but black men and women had lower rates of this condition than white men and women. The lower prevalence of thyroid dysfunction may be partially explained by the selection of healthy participants who were able to walk 0.4 km (one quarter mile) and climb stairs at baseline as part of the Health, Aging and Body Composition study. We also confirmed an association between thyrotropin and cholesterol levels and extended this association to older black adults. For men and women in both racial groups, an elevated thyrotropin level was associated with a 9 mg/dl (0.23 mmol/l) higher total cholesterol, and a suppressed thyrotropin level was associated with a 19 mg/dl (0.49 mmol/l) lower total cholesterol. The prevalence of thyroid dysfunction in older populations has varied by ethnicity. There are limited published data reporting prevalence rates of subclinical thyroid disease in nonwhite populations. Lindeman et al 24 found that non-hispanic white women have higher rates of subclinical hypothyroidism compared with Hispanic women. However, there was insufficient power to examine the relationship between thyroid status and lipid abnormalities among the different sex and ethnicity strata in this study. The only prior publication reporting the prevalence of biochemically measured hypothyroidism or hyperthyroidism in blacks is a cross-sectional analysis of community-dwelling volunteers, 55 and older, at community health fairs. 7 The authors reported a lower prevalence of hypothyroidism and hyperthyroidism in blacks vs whites, and both ethnicities had higher prevalences of the 2 disorders in women. Our results support this finding, although we found much lower prevalences of overt thyroid disease in all 4 sex and ethnicity strata overall. Likewise, older ambulatory Chinese patients in Hong Kong had low frequencies ( 2%) of abnormal thyrotropin values, with Chinese women having more thyrotropin abnormalities compared with men. 25 Among the participants who were taking thyroid hormones, most were euthyroid based on biochemical testing results. Neither sex nor race was associated with being overtreated or undertreated with thyroid hormones among this subgroup. Those with lower family income were less likely to be euthyroid, possibly because of poorer access to health care, expense of successive laboratory testing, and prescription drug costs. Those with higher levels of physical activity were also less likely to be euthyroid, an observation that is unexplained. In our evaluation of thyrotropin abnormalities and cholesterol levels, we found that a similar association exists between these 2 biochemical test results for both sexes and ethnicities. However, despite finding elevated cholesterol levels associated with high thyrotropin levels, we did not detect overtreatment of hypercholesterolemia in patients with thyroid dysfunction. Similar proportions of older adults with existing treated hypothyroidism and those with thyroid dysfunction detected on laboratory screening were taking cholesterollowering medications. Although screening older adults with increased cholesterol levels for thyroid dysfunction seems prudent, our data do not show overuse of lipidlowering drugs for those with thyroid dysfunction. We were limited to using questionnaire results and physical measurements obtained for participants at the first annual visit and using thyrotropin, FT 4, and cholesterol test results from the second annual visit for our analyses. It is unlikely that there was a significant change in most self-reported variables, such as income, physical activity, smoking, or alcohol use, during one year. With regard to the biochemical tests, serum lipid levels have high day-to-day variability, and a more accurate association between thyroid function and cholesterol level may be seen with multiple fasting levels of the test specimens drawn simultaneously. However, this additional variability would only obscure the association that we observed. We also had limited power for some associations, such as race-specific relationships between thyrotropin and cholesterol levels. When a participant s thyrotropin level was 0.1 miu/ml or less or greater than 7.0 miu/ml, FT 4 test results were obtained. Other cut points might have given slightly different results. By using our conservative cut points for ordering FT 4 testing, we were unable to determine a biochemically defined thyroid status for 41 persons with thyrotropin levels of less than 0.35 miu/ml but greater than 0.1 miu/ml and for 106 participants with thyrotropin levels of greater than 5.5 miu/ml but less than 7.0 miu/ml. Because the overall prevalences of frank hypothyroidism and hyperthyroidism were so low in persons with more strikingly abnormal thyrotropin values, we doubt that we have misclassified overt thyroid disease. However, by using these conservative variables, we may have failed to recognize more subclinical thyroid dysfunction and may have underestimated the true prevalence of subclinical hypothyroidism and hyperthyroidism. We conclude that, in individuals who were not taking thyroid hormones, overt thyroid dysfunction was less prevalent than subclinical hypothyroidism in an ambulatory biracial older population. women have equally low prevalences of subclinical thyroid disease compared with white and black men. There is an association between thyrotropin and cholesterol levels, with an elevated thyrotropin being associated with a 9 mg/dl (0.23 mmol/l) increase in cholesterol and a suppressed thyrotropin being associated with a 19 mg/dl (0.49 mmol/l) decrease in total cholesterol. Future studies should examine the association between thyrotropin levels and specific lipoprotein fractions and investigate whether thyroid autoantibodies explain the differences in thyroid dysfunction prevalences between racial groups. 778
7 Accepted for publication August 7, The Health, Aging and Body Composition study was funded by grants N01-AG , N01-AG , and N01-AG from the National Institute on Aging, National Institutes of Health, Bethesda, Md. This work was also supported by pilot investigator grant to the Center for Aging in Diverse Communities, University of California, San Francisco, funded by the National Institute on Aging, National Institute of Nursing Research, and Office of Research on Minority Health, National Institutes of Health. It was also supported by faculty development in general internal medicine grant 1D08PE from the US Department of Health and Human Services, Washington, DC (Dr Kanaya). We acknowledge and thank the reviewers of the Health, Aging and Body Composition study publications committee for their valuable contributions to manuscript revision. Corresponding author: Alka M. Kanaya, MD, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero St, Suite 554, San Francisco, CA ( REFERENCES 1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med. 2000;160: Nystrom E, Bengtsson C, Lindquist O, Noppa H, Lindstedt G, Lundberg PA. Thyroid disease and high concentration of serum thyrotropin in a population sample of women: a 4-year follow-up. Acta Med Scand. 1981;210: Falkenberg M, Kagedal B, Norr A. Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand. 1983;214: Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid: relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med. 1985;79: Rosenthal MJ, Hunt WC, Garry PT, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258: Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987;8: Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med. 1990;150: Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid: increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA. 1979;242: Samuels MH. Subclinical hypothyroid disease in the elderly. Thyroid. 1998;8: Marquess E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am. 1998;27: Arem R, Escalante D. Subclinical hypothyroidism: epidemiology, diagnosis, and significance. Adv Intern Med. 1996;41: O Brien T, Dinneen SF, O Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc. 1993;68: Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am. 1994;78: Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB. LDL/HDLchanges in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988;28: Parle JV, Frandlyn JA, Cross KW, Jones SR, Sheppard MC. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol (Oxf). 1992;37: Bogner U, Arntz HR, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol (Copenh). 1993;128: Bauer DC, Ettinger B, Browner WS. Thyroid function and serum lipids in older women: a population-based study. Am J Med. 1998;104: Ozata M, Yildirimkaya M, Yilmaz K, et al. The effects of thyroid status on serum apolipoprotein A-I containing lipoprotein particles. Horm Metab Res. 1998;30: Elder J, McLelland A, O Reilly DS, Packard CJ, Series JJ, Shepherd J. The relationship between serum cholesterol and serum thyrotropin, thyroxine and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem. 1990;27: Kung AW, Pang RW, Lauder I, Lam KS, Janus ED. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem. 1995;41: Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf). 1996;44: Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc. 1993; 25: Lohman TG, Going SB. Multicomponent models in body composition research: opportunities and pitfalls. Basic Life Sci. 1993;60: Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community [see comments]. J Am Geriatr Soc. 1999;47: Kung AW, Janus ED. Thyroid dysfunction in ambulatory elderly Chinese subjects in an area of borderline iodine intake. Thyroid. 1996;6:
ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationAmerican Thyroid Association Guidelines for Detection of Thyroid Dysfunction
American Thyroid Association Guidelines for Detection of Thyroid Dysfunction Paul W. Ladenson, MD; Peter A. Singer, MD; Kenneth B. Ain, MD; Nandalal Bagchi, MD, PhD; S. Thomas Bigos, MD; Elliot G. Levy,
More informationThyroid disease is a common medical problem. The
PERSPECTIVE Should We Be Screening for Thyroid Disease? Gay Canaris, MD, MSPH Thyroid disease is a common medical problem. The prevalence of hyperthyroidism ranges from 0.3% to 1.9%, and the prevalence
More informationORIGINAL INVESTIGATION. The Colorado Thyroid Disease Prevalence Study
ORIGINAL INVESTIGATION The Colorado Thyroid Disease Prevalence Study Gay J. Canaris, MD, MSPH; Neil R. Manowitz, PhD; Gilbert Mayor, MD; E. Chester Ridgway, MD Context: The prevalence of abnormal thyroid
More informationHigh serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism?
European Journal of Endocrinology (1998) 138 141 145 ISSN 0804-4643 High serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism?
More informationSubclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia?
ISPUB.COM The Internet Journal of Advanced Nursing Practice Volume 5 Number 1 Subclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia? A Olson Citation A Olson. Subclinical
More informationCARDIOVASCULAR DISEASES
ORIGINAL CONTRIBUTION Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults Anne R. Cappola, MD, ScM Linda P. Fried, MD, MPH Alice M. Arnold, PhD Mark D. Danese, PhD Lewis H. Kuller, MD, DrPH
More informationHYPOTHYROIDISM is more common in the elderly. Predictors of Thyroid Hormone Initiation in Older Adults: Results From the Cardiovascular Health Study
Journal of Gerontology: MEDICAL SCIENCES The Author 2011. Published by Oxford University Press on behalf of The Gerontological Society of America. Cite journal as: J Gerontol A Biol Sci Med Sci. 2011 July;66A(7):809
More informationThyroid profile in geriatric population
Original article: Thyroid profile in geriatric population Dr. Abhijit Pratap, Dr. Mona A. Tilak, Dr. Pradnya Phalak Dept of Biochemistry, Dr. D. Y. Patil Medical College, Pimpri, Pune 18 Corresponding
More informationTHE DEVELOPMENT of highly sensitive and precise
0021-972X/97/$03.00/0 Vol. 82, No. 3 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society Estimation of Tissue Hypothyroidism by a New Clinical Score:
More informationJournal of Internal Medicine 2006; 260: doi: /j x
Journal of Internal Medicine 2006; 260: 53 61 doi:10.1111/j.1365-2796.2006.01652.x Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid
More informationThe Second Report of the Expert Panel on Detection,
Blood Cholesterol Screening Influence of State on Cholesterol Results and Management Decisions Steven R. Craig, MD, Rupal V. Amin, MD, Daniel W. Russell, PhD, Norman F. Paradise, PhD OBJECTIVE: To compare
More informationSUBCLINICAL HYPOTHYROIDISM
SCIENTIFIC REVIEW AND CLINICAL APPLICATIONS CLINICIAN S CORNER Subclinical Thyroid Disease Clinical Applications Nananda F. Col, MD, MPP, MPH Martin I. Surks, MD Gilbert H. Daniels, MD SUBCLINICAL HYPOTHYROIDISM
More informationProspective Observation of 5-Year Clinical Course of Subclinical Hypothyroidism in Korean Population
ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism http://dx.doi.org/10.3346/jkms.2013.28.11.1622 J Korean Med Sci 2013; 28: 1622-1626 Prospective Observation of 5-Year Clinical Course of Subclinical
More informationThyroid Disease in Cardiovascular Patients
Thyroid Disease in Cardiovascular Patients Stuart R. Chipkin, MD Research Professor, School of Public Health and Health Sciences University of Massachusetts Disclosure Stuart R. Chipkin, MD Nothing to
More informationABSTRACT. Key words: Menopause, Dyslipidemia, Jordan, Thyroid Function. Sireen Shilbayeh, PhD Clinical Pharmacy* Introduction
THE COINCIDENCE OF THYROID GLAND DISORDERS AND DYSLIPIDEMIA DURING A CLIMACTERIC PERIOD: A HOSPITAL-BASED STUDY AT AL-BASHEER AND IBN-ALHYTHAM HOSPITALS Sireen Shilbayeh, PhD Clinical Pharmacy* ABSTRACT
More informationBiomed Environ Sci, 2017; 30(6):
Biomed Environ Sci, 2017; 30(6): 455-459 455 Letter to the Editor Serum Fetuin-A Levels and Thyroid Function in Middle-aged and Elderly Chinese * DENG Xin Ru 1,2,&, DING Lin 1,2,&, WANG Tian Ge 1,2, XU
More informationORIGINAL INVESTIGATION. Glycemic Index and Serum High-Density Lipoprotein Cholesterol Concentration Among US Adults
Glycemic Index and Serum High-Density Lipoprotein Cholesterol Concentration Among US Adults Earl S. Ford, MD; Simin Liu, MD ORIGINAL INVESTIGATION Background: Dietary glycemic index, an indicator of the
More informationVol.2 No.2 {us Taiwan Geriatr Gerontol
j Vol.2 No.2 {us Taiwan Geriatr Gerontol f {us 1 n 2 h éè r f Èu (LDL) Èu v q Ë f} vf Èu Ì{ s 46 mg dl 131 mg dl f (HDL) Èu x ˆ šá j f ( ) 1.3% - 11.2% Ç f jë {f s š ï j Ç ï f {f r Ëf k } lr r u j 2006
More informationJournal of Medical Science & Technology
Kumar AN, et al. (Jan 2012) Subclinical Hypothyroidism: Review of Concepts and Controversies. Jour of Med Sc & Journal of Medical Science & Technology Review Article Open Access Subclinical Hypothyroidism:
More informationThe Clinical Consequences and Diagnosis of Hypothyroidism
The Clinical Consequences and Diagnosis of Hypothyroidism VICKY A LEGRYS, KATHERINE HARTMANN, JOAN F WALSH ABBREVIATIONS: CVD = coronary vascular disease; FT 3 = free T 3 ; FT 4 = free T 4 ; T 3 = triiodothyronine;
More informationSupplementary Online Material
Supplementary Online Material Collet T-H, Gussekloo J, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med.
More informationHYPERTHYROIDISM IS A COMmon
ORIGINAL CONTRIBUTION Thyroid Function and Mortality in Patients Treated for Hyperthyroidism Jayne A. Franklyn, MD, PhD Michael C. Sheppard, PhD, FRCP Patrick Maisonneuve, PhD See also Patient Page. Context
More informationMastering Thyroid Disorders. Douglas C. Bauer, MD UCSF Division of General Internal Medicine
Mastering Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine Cases 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04, normal free T4 79
More informationNatural History and Comorbidities of Subjects with Subclinical Hyperthyroidism: Analysis at a Tertiary Hospital Setting
506 Original Article Natural History and Comorbidities of Subjects with Subclinical Hyperthyroidism: Analysis at a Tertiary Hospital Setting Shaikh Abdul Kader Kamaldeen Abdul Shakoor, 1 MBBS, MD, MRCP
More informationInternet Journal of Medical Update
Internet Journal of Medical Update 2012 July;7(2):3-8 Internet Journal of Medical Update Journal home page: http://www.akspublication.com/ijmu Original Work Association between different degrees of hypothyroidism
More informationTHYROID dysfunction and cigarette smoking are
964 THE NEW ENGLAND JOURNAL OF MEDICINE Oct. 12, 1995 IMPAIRED ACTION OF THYROID HORMONE ASSOCIATED WITH SMOKING IN WOMEN WITH HYPOTHYROIDISM BEAT MÜLLER, M.D., HENRYK ZULEWSKI, M.D., PETER HUBER, PH.D.,
More informationHyperthyroidism and hypothyroidism are common
Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Mark Helfand, MD, MPH Background: Subclinical thyroid dysfunction
More informationA STUDY ON PREVALANCE OF HYPOTHYROIDISM IN DIABETICS. 1.Assistant Professor,Dept of Gen. Medicine, National Institute of Medical Sciences(NIMS),Jaipur
Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 Dr Asrar Ahmed 1* A STUDY ON PREVALANCE OF HYPOTHYROIDISM IN DIABETICS 1.Assistant Professor,Dept
More informationManagement of Common Thyroid Disorders
Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures Cases 68 yr old woman with new atrial fibrillation and no other findings except TSH=0.04,
More informationLipid Profile in Thyroid Dysfunction Patients
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 12 Ver. XI (December. 2016), PP 39-43 www.iosrjournals.org Lipid Profile in Thyroid Dysfunction
More informationconcentration in young people.
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Prevalence of antithyroid antibodie concentration in young people. Sekitani, Yui; Hayashida, Naomi; Ka Kozlovsky, Alexander; Yamashita, Sh Clinical
More informationINCREASED NEED FOR THYROXINE IN WOMEN WITH HYPOTHYROIDISM DURING ESTROGEN THERAPY
INCREASED NEED FOR THYROXINE IN WOMEN WITH HYPOTHYROIDISM DURING ESTROGEN THERAPY BAHA M. ARAFAH, M.D. ABSTRACT Background Women with hypothyroidism that is being treated with thyroxine often need higher
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationNone. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives
Thyroid Potpourri for the Primary Care Physician Ramya Vedula DO, MPH, ECNU Endocrinology, Diabetes and Metabolism Princeton Medical Group Assistant Professor of Clinical Medicine Rutgers Robert Wood Johnson
More informationManagement of Common Thyroid Disorders
Cases Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04,
More informationInvestigation of thyroid dysfunction is more likely in patients with high psychological morbidity
Family Practice 2012; 29:163 167 doi:10.1093/fampra/cmr059 Advance Access published on 2 September 2011 Ó The Author 2011. Published by Oxford University Press. All rights reserved. For permissions, please
More informationDecoding Your Thyroid Tests and Results
Decoding Your Thyroid Tests and Results Wondering about your thyroid test results? Learn about each test and what low, optimal, and high results may mean so you can work with your doctor to choose appropriate
More informationPage 1. Understanding Common Thyroid Disorders. Cases. Topics Covered
Cases Understanding Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 66 yr old female with 1 yr of fatigue and lassitude and no findings except TSH=8.2,
More informationSUBCLINICAL HYPOTHYROIDISM (SCH) has been detected
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(10):4860 4866 Printed in U.S.A. Copyright 2001 by The Endocrine Society TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol
More informationSCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015
SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015 BACKGROUND Thyroid dysfunction represents a continuum from asymptomatic biochemical
More informationScreening for mild thyroid failure at the periodic health examination: a decision and costeffectiveness
Screening for mild thyroid failure at the periodic health examination: a decision and costeffectiveness analysis Danese M D, Powe N R, Sawin C T, Ladenson P W Record Status This is a critical abstract
More informationThyroid Function. Thyroid Antibodies. Analyte Information
Thyroid Function Thyroid Antibodies Analyte Information - 1-2013-04-30 Thyroid Antibodies Determination of thyroid autoantibodies are, besides TSH and FT4, one of the most important diagnostic parameters.
More informationAntithyroid drugs in Graves disease: Are we stretching it too far?
Original Article Antithyroid drugs in Graves disease: Are we stretching it too far? Muthukrishnan Jayaraman, Anil Kumar Pawah, C. S. Narayanan 1 Department of Internal Medicine, Armed Forces Medical College,
More informationSupplementary Online Content
Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant
More informationCorrelation between Thyroid Function and Bone Mineral Density in Elderly People
IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini
More informationSubclinical Hypothyroidism
Subclinical Hypothyroidism Key Clinical Points Subclinical hypothyroidism is defined as an elevated thyrotropin level with a normal free thyroxine (T 4 ) level. To confirm the diagnosis, a transient increase
More informationReference intervals are derived from the statistical distribution of values in the general healthy population.
Position Statement Subject: Thyroid Function Testing for Adult Diagnosis and Monitoring Approval Date: July 2017 Review Date: July 2019 Review By: Chemical AC, Board of Directors Number: 1/2017 Introduction:
More informationEFFECTS OF BUFFER SIZE AND SHAPE ON ASSOCIATIONS BETWEEN THE BUILT ENVIRONMENT AND ENERGY BALANCE
EFFECTS OF BUFFER SIZE AND SHAPE ON ASSOCIATIONS BETWEEN THE BUILT ENVIRONMENT AND ENERGY BALANCE PETER JAMES (HARVARD SCHOOL OF PUBLIC HEALTH) DAVID BERRIGAN (NATIONAL CANCER INSTITUTE) JAIME E HART (HARVARD
More information3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010
More informationFree triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patients
Journal of Geriatric Cardiology (2016) 13: 978 983 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Free triiodothyronine in relation to coronary severity at different ages: Gensini
More informationThyroid in the elderly. Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital
Thyroid in the elderly Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital soltania@tuma.ac.ir Case 1 A 79 year old female is seen because of a 6 month history of fatigue,
More informationCARDIOVASCULAR DISEASE IS
ORIGINAL INVESTIGATION Association Between Increased Mortality and Mild Thyroid Dysfunction in Cardiac Patients Giorgio Iervasi, MD; Sabrina Molinaro, PhD; Patrizia Landi, BSc; Maria Chiara Taddei, BSc;
More informationThyroid Function and Mortality in Older Men: A Prospective Study
ORIGINAL Endocrine ARTICLE Care Thyroid Function and Mortality in Older Men: A Prospective Study Avantika C. Waring, Stephanie Harrison, Mary H. Samuels, Kristine E. Ensrud, Erin S. LeBlanc, Andrew R.
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationLevothyroxine replacement dosage determination after thyroidectomy
The American Journal of Surgery (2013) 205, 360-364 Midwest Surgical Association Levothyroxine replacement dosage determination after thyroidectomy Judy Jin, M.D. a, Matthew T. Allemang, M.D. b, Christopher
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationX/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society
0021-972X/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Changes in Plasma Low-Density Lipoprotein (LDL)- and High-Density
More informationAssociation between serum IGF-1 and diabetes mellitus among US adults
Diabetes Care Publish Ahead of Print, published online July 16, 2010 Association between serum IGF-1 and diabetes mellitus among US adults Running title: Serum IGF-1 and diabetes mellitus Srinivas Teppala
More informationA Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
Human Journals Research Article June 2017 Vol.:9, Issue:3 All rights are reserved by Sweety George et al. A Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationSince 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.
Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research
More informationThyroid disease awareness is associated with high rates of identifying subjects with previously undiagnosed thyroid dysfunction
Canaris et al. BMC Public Health 2013, 13:351 RESEARCH ARTICLE Open Access Thyroid disease awareness is associated with high rates of identifying subjects with previously undiagnosed thyroid dysfunction
More informationSubclinical thyroid disease in elderly subjects
ACTA BIOMED 2010; 81; Suppl 1: 31-36 Mattioli 1885 R E V I E W Subclinical thyroid disease in elderly subjects Graziano Ceresini, Simonetta Morganti, Marcello Maggio, Elisa Usberti, Ilaria Fiorino, Andrea
More informationShould every pregnant woman be screened for thyroid disease?
Should every pregnant woman be screened for thyroid disease? Tal Biron-Shental Rinat Gabbay-Benziv Is there a debate? Thyroid screening Guidelines Targeted case finding criteria Age > 30 years Personal
More informationChapter I.A.1: Thyroid Evaluation Laboratory Testing
Chapter I.A.1: Thyroid Evaluation Laboratory Testing Jennifer L. Poehls, MD and Rebecca S. Sippel, MD, FACS THYROID FUNCTION TESTS Overview Thyroid-stimulating hormone (TSH) is produced by the anterior
More informationBIOSTATISTICAL METHODS
BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH PROPENSITY SCORE Confounding Definition: A situation in which the effect or association between an exposure (a predictor or risk factor) and
More informationSocioeconomic inequalities in lipid and glucose metabolism in early childhood
10 Socioeconomic inequalities in lipid and glucose metabolism in early childhood Gerrit van den Berg, Manon van Eijsden, Francisca Galindo-Garre, Tanja G.M. Vrijkotte, Reinoud J.B.J. Gemke BMC Public Health
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationThyroid Function Test Ordering Pattern in a Tertiary Care Hospital in Western Uttar Pradesh, India.
Research and Reviews: Journal of Medical and Health Sciences Thyroid Function Test Ordering Pattern in a Tertiary Care Hospital in Western Uttar Pradesh, India. Rajni Dawar Mahajan *, Tabassum Yasmin,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our
More informationAssessment of the Cardiovascular Risk in Subclinical Hypothyroidism
Page128 Assessment of the Cardiovascular Risk in Subclinical Hypothyroidism Anand Pyati* 1, Sudharani Dhuttargi 2, Nagaraj 1, Debasmita Das 3 1 Department of Biochemistry, BLDEU s Shri B M Patil Medical
More informationDiscontinuation of Smoking Increases the Risk for Developing Thyroid Peroxidase Antibodies and/or Thyroglobulin Antibodies: A Prospective Study
ORIGINAL ARTICLE Endocrine Care Brief Report Discontinuation of Smoking Increases the Risk for Developing Thyroid Peroxidase Antibodies and/or Thyroglobulin Antibodies: A Prospective Study Grigoris Effraimidis,
More informationSubclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure
Journal of the American College of Cardiology Vol. 52, No. 14, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.009
More informationPREVALENCE OF THYROID DISORDERS IN A TERTIARY CARE CENTER
IJCRR Section: Healthcare Sci. Journal Impact Factor 4.016 Research Article PREVALENCE OF THYROID DISORDERS IN A TERTIARY CARE CENTER Deokar PG 1, Nagdeote AN 2, Lanje MJ 3, Basutkar DG 4 1 Senior Resident
More informationThe New England Journal of Medicine MORTALITY AFTER THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE. Subjects
MORTALITY AFTER THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE J.A. FRANKLYN, M.D., PH.D., P. MAISONNEUVE, PH.D., M.C. SHEPPARD, PH.D., F.R.C.P., J. BETTERIDGE, R.G.N., AND P. BOYLE, PH.D. ABSTRACT
More informationSubclinical hypothyroidism (SCH) is defined by mildly
ORIGINAL Endocrine ARTICLE Care Subclinical Hypothyroidism and Indices for Metabolic Syndrome in Japanese Women: One-Year Follow-Up Study Yasuyo Nakajima,* Masanobu Yamada,* Masako Akuzawa, Sumiyasu Ishii,
More informationUnderstanding thyroid function tests. Dr. Colette George
Understanding thyroid function tests Dr. Colette George Disclosures No financial disclosure I will present fictitious cases and thyroid function tests (TFTs) that are based on scenarios I commonly encounter.
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationORIGINAL INVESTIGATION. Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease
ORIGINAL INVESTIGATION Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease Lynn E. Eberly, PhD; Jeremiah Stamler, MD; James D. Neaton, PhD; for the Multiple
More informationThyroid Dysfunction Associated with Coronary Heart Disease Barghchi E and Azizi F.
Is Thyroid Dysfunction Associated with Coronary Heart Disease? Elaheh Barghchi 1*, Fereidoun Azizi 2 1 Endocrinologist, Internal Medicine, Department of Endocrinology, University of Medical Sciences, Mashhad,
More informationHypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,
More informationOriginal Article. 106
Original Article Endocrinol Metab 217;32:16-114 https://doi.org/1.383/enm.217.32.1.16 pissn 293-596X eissn 293-5978 Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in
More informationROKSANA KARIM, MBBS, PHD UNIVERSITY OF SOUTHERN CALIFORNIA LOS ANGELES, CA
Gonadotropin and Sex Steroid Levels in HIVinfected Premenopausal Women and Their Association with Subclinical Atherosclerosis in HIVinfected and -uninfected Women in the Women s Interagency HIV Study (WIHS)
More informationNational public health campaigns have attempted
WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,
More informationCardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents. Queen s University Kingston, Ontario, Canada
Diabetes Care In Press, published online May 29, 2007 Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents Received for publication 16 April 2007 and accepted in revised
More informationEffectiveness Of Fixed Dose Radioactive Iodine (Rai) For The Treatment Of Thyrotoxicosis : A United Kingdom District General Hospital Experience
ISPUB.COM The Internet Journal of Endocrinology Volume 5 Number 2 Effectiveness Of Fixed Dose Radioactive Iodine (Rai) For The Treatment Of Thyrotoxicosis : A United Kingdom District General Hospital Experience
More informationJournal of Clinical and Biomedical Sciences. Serum Lipoprotein (a) and lipid profile in Hypothyroidism.
235 Journal of Clinical and Biomedical Sciences Journal homepage: www.jcbsonline.ac.in Clinical Investigation Serum Lipoprotein (a) and lipid profile in Hypothyroidism. Shilpashree M K 1 *, Ravi B V 2,
More informationORIGINAL INVESTIGATION. A Prospective Study of Physical Activity and Cognitive Decline in Elderly Women
A Prospective Study of Physical Activity and Cognitive Decline in Elderly Women Women Who Walk ORIGINAL INVESTIGATION Kristine Yaffe, MD; Deborah Barnes, MPH; Michael Nevitt, PhD; Li-Yung Lui, MA, MS;
More informationAssociation between multiple comorbidities and self-rated health status in middle-aged and elderly Chinese: the China Kadoorie Biobank study
Song et al. BMC Public Health (2018) 18:744 https://doi.org/10.1186/s12889-018-5632-1 RESEARCH ARTICLE Association between multiple comorbidities and self-rated health status in middle-aged and elderly
More informationPUBLICAÇÃO TRIMESTRAL
Original Articles Prospective study of T, T and values in elderly female patients admitted in an Internal Medicine service Fátima Duarte*, Fernanda Carrilho*, Mário Santos**, Ana Fragoso***, Ana Mouro****,
More informationThyroid Hormone and Coronary Artery Disease: From Clinical Correlations to Prognostic Implications
Thyroid Hormone and Coronary Artery Disease: From Clinical Correlations to Prognostic Implications Address for correspondence: Michele Coceani, MD Via Moruzzi 1 56124 Pisa, Italy michecoc@ifc.cnr.it Michele
More informationA cross-sectional survey of relationship between serum TSH level and blood pressure
(2010) 24, 134 138 & 2010 Macmillan Publishers Limited All rights reserved 0950-9240/10 $32.00 www.nature.com/jhh JHH Open ORIGINAL ARTICLE A cross-sectional survey of relationship between serum TSH level
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationDisorders of Thyroid Function
Disorders of Thyroid Function Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Thyroid Hormone Axis Hypothalamus TRH
More informationjournal of medicine The new england Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Abstract
The new england journal of medicine established in 1812 november 20, 2008 vol. 359 no. 21 to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M Ridker, M.D., Eleanor Danielson,
More informationORIGINAL INVESTIGATION. Smoking and Other Lifestyle Factors and the Risk of Graves Hyperthyroidism
ORIGINAL INVESTIGATION Smoking and Other Lifestyle Factors and the Risk of Graves Hyperthyroidism Ingrid A. Holm, MD, MPH; JoAnn E. Manson, MD, DrPH; Karin B. Michels, ScD, MPH; Erik K. Alexander, MD;
More informationMethods of Calculating Deaths Attributable to Obesity
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 160, No. 4 Printed in U.S.A. DOI: 10.1093/aje/kwh222 Methods of Calculating
More information